Ahmad Shah, Le Christopher H, Chiu Alexander G, Chang Eugene H
Department of Otolaryngology-Head and Neck Surgery, University of Arizona, College of Medicine, Tucson, Arizona, U.S.A.
Department of Otolaryngology-Head and Neck Surgery, University of Arizona, College of Medicine, Tucson, Arizona, U.S.A..
Laryngoscope. 2016 Nov;126(11):2445-2450. doi: 10.1002/lary.26106. Epub 2016 Jun 14.
OBJECTIVES/HYPOTHESIS: Surgery and postoperative radiation therapy are commonly used in the treatment of advanced sinonasal cancer. However, post-treatment radiation changes to the brain often mimic radiologic findings suggestive of tumor recurrence, leading to potential unnecessary intracranial biopsies. The objective of this study was to determine clinical factors that predict signs of tumor recurrence versus radiation necrosis in post-therapy sinonasal malignancies with intracranial extension.
Retrospective study.
Twenty-six patients with sinonasal malignancy with intracranial extension underwent surgery and radiation ± chemotherapy between 2010 and 2014 at the University of Arizona. We analyzed sinonasal cancer type, stage, total radiation dosimetry, time until imaging changes, surgical pathology, associated imaging, and patient demographics.
Thirteen of 26 patients had postoperative imaging changes seen on surveillance magnetic resonance imaging (MRI). Five were deemed to have tumor recurrence due to new metastasis seen on positron emission tomography/computed tomography scan. Four patients were observed with serial imaging that confirmed pseudoprogression. In four patients, there was sufficient concern due to persistent MRI changes, which prompted surgical biopsy, and only one of them was positive for tumor recurrence. Factors that favored tumor recurrence included faster onset of imaging changes on MRI (55 vs. 186 days, P < .05).
Intracranial tumor recurrence can be difficult to distinguish between radiation necrosis in sinonasal cancers treated with surgery and postoperative radiation ± chemotherapy. Patients with sub-total resection and rapid onset of MRI changes in postsurveillance scans are more likely to have tumor recurrence versus radiation necrosis. Future imaging techniques or tests that investigate tumor biomarkers are necessary to prevent unnecessary biopsies.
4 Laryngoscope, 126:2445-2450, 2016.
目的/假设:手术和术后放射治疗常用于晚期鼻窦癌的治疗。然而,治疗后脑部的放射改变常常类似于提示肿瘤复发的影像学表现,导致可能进行不必要的颅内活检。本研究的目的是确定能够预测接受治疗的伴有颅内侵犯的鼻窦恶性肿瘤出现肿瘤复发迹象与放射性坏死迹象的临床因素。
回顾性研究。
2010年至2014年期间,26例伴有颅内侵犯的鼻窦恶性肿瘤患者在亚利桑那大学接受了手术及放疗±化疗。我们分析了鼻窦癌的类型、分期、总放射剂量、出现影像学改变的时间、手术病理、相关影像学检查以及患者人口统计学资料。
26例患者中有13例在监测磁共振成像(MRI)上出现了术后影像学改变。5例因正电子发射断层扫描/计算机断层扫描发现新的转移灶而被认为有肿瘤复发。4例患者通过系列影像学检查观察到证实为假性进展。4例患者因MRI持续改变而引起足够关注,从而进行了手术活检,其中只有1例肿瘤复发呈阳性。提示肿瘤复发的因素包括MRI上影像学改变出现得更快(55天对186天,P <.05)。
在接受手术及术后放疗±化疗的鼻窦癌中,颅内肿瘤复发可能难以与放射性坏死相区分。与放射性坏死相比,接受次全切除且监测扫描中MRI改变出现迅速的患者更有可能出现肿瘤复发。未来需要成像技术或检测肿瘤生物标志物的检查以避免不必要的活检。
4 喉镜,126:2445 - 2450,2016年。